Vitt Daniel's most recent trade in Immunic Inc was a trade of 1,720,000 Stock Appreciation Right done . Disclosure was reported to the exchange on July 16, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Immunic Inc | Daniel Vitt | Director, CEO and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2025 | 1,720,000 | 1,720,000 | - | - | Stock Appreciation Right | |
| Immunic Inc | Daniel Vitt | Director, CEO and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2025 | 1,720,000 | 1,720,000 | - | - | Stock Appreciation Right | |
| Immunic Inc | Daniel Vitt | Director, CEO and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2025 | 860,000 | 860,000 | - | - | Stock Appreciation Right | |
| Immunic Inc | Daniel Vitt | Director, CEO and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2025 | 860,000 | 860,000 | - | - | Stock Appreciation Right | |
| Immunic Inc | Daniel Vitt | Director, CEO and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2025 | 860,000 | 860,000 | - | - | Stock Appreciation Right | |
| Immunic Inc | Daniel Vitt | Director, CEO and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 1,558,000 | 1,558,000 | - | - | Stock Option | |
| Immunic Inc | Daniel Vitt | Director, CEO and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 1,535,000 | 1,535,000 | - | - | Stock Option | |
| Immunic Inc | Daniel Vitt | Director, CEO and Director | Purchase of securities on an exchange or from another person at price $ 0.77 per share. | 04 Jun 2025 | 15,000 | 29,000 (0%) | 0% | 0.8 | 11,550 | Common Stock |
| Immunic Inc | Daniel Vitt | Director, CEO and Director | Purchase of securities on an exchange or from another person at price $ 0.77 per share. | 04 Jun 2025 | 15,000 | 29,000 (0%) | 0% | 0.8 | 11,550 | Common Stock |
| Immunic Inc | Daniel Vitt | Director, CEO and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2024 | 820,000 | 820,000 | - | - | Stock Option | |
| Immunic Inc | Daniel Vitt | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 485,000 | 485,000 | - | - | Stock Option | |
| Immunic Inc | Daniel Vitt | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Mar 2024 | 215,000 | 0 | - | - | Stock Option | |
| Immunic Inc | Daniel Vitt | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Mar 2024 | 115,000 | 0 | - | - | Stock Option | |
| Immunic Inc | Daniel Vitt | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Mar 2024 | 80,000 | 0 | - | - | Stock Option | |
| Immunic Inc | Daniel Vitt | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Mar 2024 | 65,000 | 0 | - | - | Stock Option | |
| Immunic Inc | Daniel Vitt | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Mar 2024 | 10,000 | 0 | - | - | Stock Option | |
| Immunic Inc | Vitt Daniel | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.31 per share. | 26 Feb 2024 | 14,000 | 390,877 (3%) | 0% | 1.3 | 18,333 | Common Stock |
| Immunic Inc | Vitt Daniel | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2024 | 1,160,000 | 1,160,000 | - | - | Stock Option | |
| Immunic Inc | Daniel Vitt | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2023 | 300,000 | 300,000 | - | - | Stock Option | |
| Immunic Inc | Daniel Vitt | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.35 per share. | 22 Nov 2022 | 8,000 | 376,877 (3%) | 0% | 1.3 | 10,799 | Common Stock |
| Immunic Inc | Daniel Vitt | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 3.10 per share. | 03 Jun 2022 | 5,000 | 368,877 (3%) | 0% | 3.1 | 15,500 | Common Stock |
| Immunic Inc | Daniel Vitt | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 215,000 | 215,000 | - | - | Stock Option | |
| Immunic Inc | Daniel Vitt | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 9.60 per share. | 10 Aug 2021 | 1,000 | 363,877 (3%) | 0% | 9.6 | 9,600 | Common Stock |
| Immunic Inc | Daniel Vitt | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 115,000 | 115,000 | - | - | Stock Option |